Raredr

NORD Goes Live with Q&A about American Health Care Act and Other Policies

Published Online: Thursday, Mar 16, 2017
Tim Boyd and Paul Melmeyer from NORD's policy team were on Facebook Live earlier today. Below is their posting. Tim and Paul talked for over 50 minutes about various policy issues relevant to the rare disease community, including the Affordable Care Act, and its proposed replacement, the American Health Care Act.


For more information, visit www.raredisease.org and visit our NORD partner page at www.raredr.com/sap-partner/nord
 

Latest Articles
eSight eyewear is the Star Trek like device that allows legally blind 13-year-old, Ethan LaCroix, the ability to play basketball with the Harlem Globetrotters
The 2017 Neuro Film Festival awarded William T. Doorley with the Neuroscience Is…™ Essential award for “Work in Progress: The Remarkable Journey of Dr. Warden.”
Brineura (cerliponase alfa) is an enzyme replacement therapy that in just a few short years has shown itself to be an effective treatment for children with CLN2 disease.
The 2017 Neuro Film Festival recently awarded Meghan Tucker with the Neuroscience Is…™ Critical award for her video, “BethAnn Telford World Marathon Challenge.”
$vacMongoViewPlus$ $vAR$